This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,363 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
A major asset sale could recalibrate FMC’s balance sheet and growth trajectory. This guide breaks down what the deal ...
When a high-ranking executive sells stock, investors scramble for answers. This article breaks down the move by fermi...
When a top executive sells shares, investors tune in. This article breaks down what a recent move by Ladder Capital's...
A bold treasury move turned Bitcoin into dividends. This practical look at a BTC monetization program reveals how lar...
A tiny insider sale can spark big questions. This article explains what’s behind $211,680 sale, how Vicor’s AI-led de...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
Health Savings Accounts offer powerful tax advantages, but a hidden rule can dramatically affect how much you can con...
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
Crypto fund flows are shifting. While bitcoin, ethereum etfs shed money, hyperliquid funds are drawing fresh buyers i...
The market is higher in 2026, but smart investors know steady, disciplined ETF investing still pays. This guide break...